DMK PHARMACEUTICALS CORPORATION Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
DMK PHARMACEUTICALS CORPORATION reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 68.00% for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2016-05-13
- DMK PHARMACEUTICALS CORPORATION fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 68.00%.
- DMK PHARMACEUTICALS CORPORATION fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2012-06-30 was 87.60%.
- DMK PHARMACEUTICALS CORPORATION fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 72.50%, a 19.44% decline from fiscal 2014.
- DMK PHARMACEUTICALS CORPORATION fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2014 was 90.00%.
- DMK PHARMACEUTICALS CORPORATION fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 92.10%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2016-03-31 | 68.00% 10-Q · filed 2016-05-13 | ||
| 2015-12-31 | 72.50% 10-K · filed 2016-03-23 | ||
| 2015-09-30 | 84.00% 10-Q · filed 2015-11-09 | ||
| 2014-12-31 | 90.00% 10-K · filed 2016-03-23 | ||
| 2013-03-31 | 92.10% 10-K · filed 2013-07-03 | ||
| 2012-06-30 | 87.60% 10-Q/A · filed 2012-08-17 |